148 related articles for article (PubMed ID: 28337372)
41. miR-543 promotes colorectal cancer proliferation and metastasis by targeting
Zhai F; Cao C; Zhang L; Zhang J
Oncotarget; 2017 Aug; 8(35):59246-59256. PubMed ID: 28938633
[TBL] [Abstract][Full Text] [Related]
42. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
Tokarz P; Blasiak J
Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124
[TBL] [Abstract][Full Text] [Related]
43. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869
[TBL] [Abstract][Full Text] [Related]
44. The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer.
He GY; Hu JL; Zhou L; Zhu XH; Xin SN; Zhang D; Lu GF; Liao WT; Ding YQ; Liang L
Br J Cancer; 2016 Nov; 115(11):1367-1378. PubMed ID: 27811858
[TBL] [Abstract][Full Text] [Related]
45. miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP.
Li X; Zhang X; Zhang Q; Lin R
Int J Biochem Cell Biol; 2019 Jun; 111():27-36. PubMed ID: 30974224
[TBL] [Abstract][Full Text] [Related]
46. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
Wang YX; Chen YR; Liu SS; Ye YP; Jiao HL; Wang SY; Xiao ZY; Wei WT; Qiu JF; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Dec; 7(51):84826-84838. PubMed ID: 27769041
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of microRNA-126 is inversely correlated with insulin receptor substrate-1 protein expression in colorectal cancer and is associated with advanced stages of disease.
Ye S; Yu C; Zhang G; Shi F; Chen Y; Yang J; Wu W; Zhou Y
Oncol Lett; 2020 Sep; 20(3):2411-2419. PubMed ID: 32782558
[TBL] [Abstract][Full Text] [Related]
48. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
[TBL] [Abstract][Full Text] [Related]
49. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
50. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
51. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
[TBL] [Abstract][Full Text] [Related]
52. Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer.
Qin J; Ke J; Xu J; Wang F; Zhou Y; Jiang Y; Wang Z
Onco Targets Ther; 2015; 8():3639-48. PubMed ID: 26675712
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
[TBL] [Abstract][Full Text] [Related]
54. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
[TBL] [Abstract][Full Text] [Related]
55. miR-6852 serves as a prognostic biomarker in colorectal cancer and inhibits tumor growth and metastasis by targeting TCF7.
Cui BH; Hong X
Exp Ther Med; 2018 Aug; 16(2):879-885. PubMed ID: 30116340
[TBL] [Abstract][Full Text] [Related]
56. Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer.
Kou CH; Zhou T; Han XL; Zhuang HJ; Qian HX
Oncol Lett; 2016 Dec; 12(6):4838-4844. PubMed ID: 28101227
[TBL] [Abstract][Full Text] [Related]
57. miR-429 mediates tumor growth and metastasis in colorectal cancer [Retraction].
Am J Cancer Res; 2020; 10(8):2688. PubMed ID: 32905532
[TBL] [Abstract][Full Text] [Related]
58. MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2.
Chen X; Wang AL; Liu YY; Zhao CX; Zhou X; Liu HL; Lin MB
Oxid Med Cell Longev; 2020; 2020():5316276. PubMed ID: 33414893
[TBL] [Abstract][Full Text] [Related]
59. PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR.
Lv J; Guo T; Qu X; Che X; Li C; Wang S; Gong J; Wu P; Liu Y; Liu Y; Xu L
Front Oncol; 2020; 10():1067. PubMed ID: 32775300
[TBL] [Abstract][Full Text] [Related]
60. miR-429 inhibits osteosarcoma progression by targeting HOXA9 through suppressing Wnt/β-catenin signaling pathway.
Sun L; Wang L; Luan S; Jiang Y; Wang Q
Oncol Lett; 2020 Sep; 20(3):2447-2455. PubMed ID: 32782562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
